| HOME >> MEDICINE >> TECHNOLOGY |
Table 77: Clinical Trial 1, Genous Bio-engineered R-Stent 99
Table 78: Clinical Trial 2, Genous Bio-engineered R-Stent 100
Table 79: Product Status, Twin-Rail Bare Metal Stent 102
Table 80: Clinical Trial 1, Twin-Rail Bare Metal Stent 103
List of Figures
Figure 1: Coronary Heart Disease, Signs and Symptoms 11
Figure 2: Bare Metal Stents Market, Global, Revenue ($m), 2003–2010 14
Figure 3: Bare Metal Stents Market, Global, Volume ('000), 2003–2010 15
Figure 4: Bare Metal Stents Market, Global, Revenue ($m), 2010–2017 16
Figure 5: Bare Metal Stents Market, Global, Volume ('000), 2010–2017 17
Figure 6: Bare Metal Stents, Market Dynamics 18
Figure 7: Coronary Heart Disease, the US, Prevalence (%), 2010-2030 19
Figure 8: Coronary Heart Disease in Men by Age, the UK, Prevalence (%), 2000-2008 20
Figure 9: Coronary Heart Disease in Women by Age, the UK, Prevalence (%), 2000-2008 21
Figure 10: Population Aged 65 and Above (million), Global, 2004-2010 22
Figure 11: Population Aged 60 and Above (million), and Population Aged 60 and Above as a Percentage (%) of Adult Population*, the US, 2000–2050 23
Figure 12: Prevalence of Coronary Heart Disease in Population Aged between 60-79 and Aged 80 and over, the US, Prevalence (%), 2006 24
Figure 13: Tobacco Consumption, Global, Population (billion), 2000–2050 25
Figure 14: Comparison of Alloys used in the Manufacture of Bare Metal Stents 27
Figure 15: Bare Metal Stents, the US, Average Selling Price ($), 2003-2010 29
Figure 16: Bare Metal Stents Market, the US, Revenue ($m), 2003–2010 30
Figure 17: Bare Metal Stents Market, the US, Volume ('000), 2003–2010 31
Figure 18: Bare Metal Stents Market, the US, Revenue ($m), 2010–2017 32
Figure 19: Bare Metal Stents Market, the US, Volume ('000), 2010–2017
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |